Clinical Immunology · Agammaglobulinemia 7

Living with AGM7: Monitoring and Long-term Care

At a Glance

Children with Agammaglobulinemia 7 need lifelong immunoglobulin replacement and individualized monitoring. Infection prevention includes avoiding live vaccines, vaccinating household members, hand hygiene, school planning, and selective lung checks.

Managing Agammaglobulinemia 7 (AGM7) is a lifelong commitment to protection and prevention. While your child will face unique health challenges, the goal of long-term care is to ensure they can participate safely in school, hobbies, and social life ^[1]^[2].

Ongoing Monitoring: Individualized Care

Because your child’s antibody levels depend entirely on their infusions, your medical team will perform regular “check-ups.”

IgG Trough Levels: Before an infusion, doctors may measure the trough level—the lowest amount of IgG in the blood ^[3]. There is no single universal “perfect” number that guarantees protection. Your immunologist will set an individualized target based on your child’s infection history, weight, route of administration, and overall health ^[4]^[5].
Dose Adjustments: As your child grows or if breakthrough infections occur, their dose may be adjusted to match their clinical needs ^[4].
Organ Health: Depending on the specific immunoglobulin product used and your child’s individual risk factors, your doctor may periodically check liver and kidney function ^[6].

Protecting the Lungs

A significant long-term risk for children with agammaglobulinemia is bronchiectasis, a condition where the airways become permanently scarred due to repeated bouts of pneumonia or bronchitis ^[7]^[8].

Pulmonary Monitoring: Lung surveillance is highly individualized. This may include spirometry (breathing tests) once they are old enough to follow the instructions ^[9]^[10].
Selective Imaging: CT scans involve radiation, so they are used selectively. If your child has a persistent cough or frequent lung infections, a High-Resolution CT (HRCT) scan may be ordered to catch structural changes ^[11]^[12].

The Rules of Vaccination

Vaccination in profound B-cell deficiency requires a specific strategy.

Live Vaccines (Strictly Avoided for the Child): Live-attenuated vaccines are generally contraindicated for your child and must be avoided, as the weakened viruses can grow and cause the disease ^[13]^[14]. These include the oral polio vaccine, rotavirus, MMR (measles, mumps, rubella), the nasal spray flu vaccine, and varicella (chickenpox) ^[15]^[16].
Inactivated Vaccines: Vaccines made with “killed” viruses (like the standard flu shot) are generally safe ^[13]. However, because your child lacks B cells, antibody responses may be entirely absent, so protection from these vaccines should not be assumed ^[17]^[18].
The “Cocoon” Strategy (Household Contacts): Your child does not need to be socially isolated from people who receive vaccines. In fact, household members should receive their recommended routine vaccines to create a “cocoon” of protection ^[19]^[20]. There are a few specific precautions: if a baby in the house gets the rotavirus vaccine, avoid contact with their stool; if someone gets the varicella vaccine and develops a rash, avoid the rash. Your immunologist will provide a definitive household vaccine list.

Life at School and Home

Your child does not need to live in a “bubble,” but they do need a proactive environment.

Hygiene Habits: Teaching your child thorough hand-washing is one of the most effective ways to prevent the spread of germs ^[21]. Keep in mind that AGM7 itself is not contagious, though any infections your child catches can be.
School Health Plan: Provide your child’s school with a written health plan from your immunologist. This should include a concrete exposure and return-to-school plan, requiring the school to notify you immediately if there is an outbreak of a live-virus illness (like chickenpox or measles) so your medical team can initiate post-exposure protocols if needed ^[1].

Common questions in this guide

How are IgG infusion doses and trough targets chosen for a child with AGM7?

A trough level is the lowest IgG level measured just before an infusion. There is no single target for every child; the immunologist adjusts the target and dose according to infection history, growth and weight, infusion route, and overall health.

Which vaccines are unsafe for children with AGM7?

Live-attenuated vaccines, including oral polio, rotavirus, MMR, nasal-spray flu, and varicella vaccines, are generally avoided because weakened viruses can cause illness. Inactivated vaccines such as the standard flu shot are generally safe, but the child may not make enough antibodies for reliable protection.

Should household members be vaccinated when a child has AGM7?

Household members should generally receive their recommended routine vaccines to help protect the child. After a baby receives rotavirus vaccine, avoid contact with the baby's stool; if someone develops a rash after varicella vaccination, avoid contact with the rash and ask the immunologist for specific guidance.

How is lung health monitored in children with AGM7?

Monitoring may include spirometry once a child is old enough to follow breathing-test instructions. High-resolution CT is used selectively, especially when there is a persistent cough or frequent lung infections, because it involves radiation and can identify structural changes such as bronchiectasis.

Can a child with AGM7 attend school and take part in activities?

AGM7 does not require social isolation, and many children can participate with proactive precautions. Handwashing and a written school health plan can help staff respond quickly to outbreaks, illness exposures, and return-to-school decisions.

What is bronchiectasis, and why is it a concern in AGM7?

Bronchiectasis is permanent scarring of the airways that can develop after repeated pneumonia or bronchitis. Because it is a long-term risk in children with agammaglobulinemia, the medical team may use breathing tests and selective imaging to monitor lung health.

Is AGM7 contagious?

AGM7 itself is not contagious because it is an inherited immune deficiency. However, infections a child catches can spread to other people, so household and school illness-prevention measures remain important.

Get notified when new evidence is published on agammaglobulinemia 7, autosomal recessive.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (21)

1
Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early Diagnosis.
Blom M, Duintjer AJ, Jamee M, et al.
Journal of clinical immunology 2025; (45(1)):125.
PMID: 40853601
2
Clinical and Molecular Characteristics of X-Linked Agammaglobulinemia Patients 55 Years or Older.
Chin AT, Ochs HD, Kobayashi R, et al.
The journal of allergy and clinical immunology. In practice 2025; (13(10)):2806-2816.e6 doi:10.1016/j.jaip.2025.06.025.
PMID: 40571245
3
An update on X-Linked agammaglobulinaemia: clinical manifestations and management.
Shillitoe BMJ, Gennery AR
Current opinion in allergy and clinical immunology 2019; (19(6)):571-577 doi:10.1097/ACI.0000000000000584.
PMID: 31464718
4
Immunoglobulin G Trough Levels and Infection Risk in Adults with Inborn Errors of Immunity Receiving Immunoglobulin Therapy.
Aktaş ÖÖ, Özer NO, Kaplankıran C, et al.
Medicina (Kaunas, Lithuania) 2025; (61(9)) doi:10.3390/medicina61091549.
PMID: 41010940
5
Current Spectrum of Infections in Patients with X-Linked Agammaglobulinemia.
Paccoud O, Mahlaoui N, Moshous D, et al.
Journal of clinical immunology 2021; (41(6)):1266-1271 doi:10.1007/s10875-021-01043-1.
PMID: 33880703
6
Discordant Phenotypes of Nephritis in Patients with X-linked Agammaglobulinemia.
Kanamori T, Udagawa T, Fujii T, et al.
Journal of clinical immunology 2024; (44(7)):164 doi:10.1007/s10875-024-01766-x.
PMID: 39052129
7
Clinical and Genetic Profile of X-Linked Agammaglobulinemia: A Multicenter Experience From India.
Rawat A, Jindal AK, Suri D, et al.
Frontiers in immunology 2020; (11()):612323 doi:10.3389/fimmu.2020.612323.
PMID: 33584693
8
Outcomes of X-Linked Agammaglobulinaemia Patients.
Shillitoe B, Duque JSR, Lai SHY, et al.
Journal of clinical immunology 2024; (45(1)):40.
PMID: 39541002
9
Evaluation of respiratory complications in patients with X-linked and autosomal recessive agammaglobulinemia.
Fekrvand S, Yazdani R, Olbrich P, et al.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2020; (31(4)):405-417 doi:10.1111/pai.13228.
PMID: 32058651
10
Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working group.
Jolles S, Sánchez-Ramón S, Quinti I, et al.
Clinical and experimental immunology 2017; (190(2)):226-234 doi:10.1111/cei.13012.
PMID: 28708268
11
Evaluation of pulmonary findings in patients with humoral immunodeficiency.
Karalı Z, Karalı Y, Çekiç Ş, et al.
Turk pediatri arsivi 2020; (55(2)):174-183 doi:10.14744/TurkPediatriArs.2020.46656.
PMID: 32684763
12
Respiratory Health and Related Quality of Life in Patients with Congenital Agammaglobulinemia in the Northern Region of the UK.
Bryan BA, Battersby A, Shillitoe BM, et al.
Journal of clinical immunology 2016; (36(5)):472-9 doi:10.1007/s10875-016-0284-3.
PMID: 27091141
13
Vaccination in PADs.
Milito C, Soccodato V, Collalti G, et al.
Vaccines 2021; (9(6)) doi:10.3390/vaccines9060626.
PMID: 34207916
14
Vaccination in Primary Immunodeficiency Disorders.
Sobh A, Bonilla FA
The journal of allergy and clinical immunology. In practice 2016; (4(6)):1066-1075 doi:10.1016/j.jaip.2016.09.012.
PMID: 27836056
15
Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity.
Pöyhönen L, Bustamante J, Casanova JL, et al.
Journal of clinical immunology 2019; (39(4)):376-390 doi:10.1007/s10875-019-00642-3.
PMID: 31123910
16
Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians' perspectives in the endgame plan for polio eradication.
Galal NM, Meshaal S, ElHawary R, et al.
BMC research notes 2018; (11(1)):717 doi:10.1186/s13104-018-3822-7.
PMID: 30305145
17
Response to mRNA COVID-19 vaccination in three XLA patients.
Squire JD, Joshi AY
Vaccine 2022; (40(36)):5299-5301 doi:10.1016/j.vaccine.2022.07.046.
PMID: 35934578
18
Cellular immune response to SARS-CoV-2 in patients with primary antibody deficiencies.
Mizera D, Dziedzic R, Drynda A, et al.
Frontiers in immunology 2023; (14()):1275892 doi:10.3389/fimmu.2023.1275892.
PMID: 37901210
19
Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID).
Mieves JF, Wittke K, Freitag H, et al.
Current allergy and asthma reports 2017; (17(11)):78 doi:10.1007/s11882-017-0749-3.
PMID: 28983790
20
Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency.
Hanitsch LG, Löbel M, Mieves JF, et al.
Vaccine 2016; (34(21)):2417-2423 doi:10.1016/j.vaccine.2016.03.091.
PMID: 27055021
21
"It's a Godsend": Parental experiences of genomic testing for paediatric inborn errors of immunity.
Clark A, DeBortoli E, Blancoe M, et al.
European journal of human genetics : EJHG 2025; (33(10)):1342-1349 doi:10.1038/s41431-025-01917-7.
PMID: 40730688

This page is for informational purposes only and does not constitute medical advice. Your child’s immunologist should personalize infusion schedules, vaccine precautions, lung monitoring, and plans for illness exposures.